Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Lung Cancer

Free Subscription 16.01.2012 1 Am J Clin Oncol 1 Am J Ind Med 1 Ann Surg 1 Ann Surg Oncol 1 Br J Cancer 1 Cancer 1 Cancer Cell 3 Cancer Chemother Pharmacol 1 Cancer Lett 3 Cancer Res 5 Clin Cancer Res 5 Clin Exp Metastasis 2 Clin Lung Cancer 1 Clin Nucl Med 6 Eur J Cardiothorac Surg 1 Int J Oncol 1 J Cancer Res Clin Oncol 1 J Immunol 2 J Natl Cancer Inst 1 J Nucl Med 1 J Thorac Cardiovasc Surg 5 J Thorac Oncol 7 Lung Cancer 1 Mol Carcinog 2 N Engl J Med 1 Oncogene 1 Oncol Rep 1 Proc Natl Acad Sci U S A 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Oncol

1. KIM ST , Jung HY, Sung JS, Jo UH, et al
   Can Serum be Used for Analyzing the EGFR Mutation Status in Patients with Advanced Non-small Cell Lung Cancer?
   Am J Clin Oncol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Am J Ind Med

2. CALVERT GM , Luckhaupt S, Lee SJ, Cress R, et al
   Lung cancer risk among construction workers in California, 1988-2007.
   Am J Ind Med. 2012 Jan 11. doi: 10.1002/ajim.22010.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Ann Surg

3. WELVAART WN , Paul MA, Stienen GJ, van Hees HW, et al
   Selective diaphragm muscle weakness after contractile inactivity during thoracic surgery.
   Ann Surg. 2011;254:1044-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Ann Surg Oncol

4. FUNAI K , Sugimura H, Morita T, Shundo Y, et al
   Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma.
   Ann Surg Oncol. 2011;18:2968-72.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Br J Cancer

5. MCCORMACK V , Peto J, Byrnes G, Straif K, et al
   Estimating the asbestos-related lung cancer burden from mesothelioma mortality.
   Br J Cancer. 2012 Jan 10. doi: 10.1038/bjc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer

6. PRINTZ C
   Celecoxib may prevent lung cancer.
   Cancer. 2012;118:3.
   PubMed     Text format     Related articles   
   
   
   

   
   Cancer Cell

7. LABELLE M , Begum S, Hynes RO
   Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.
   Cancer Cell. 2011;20:576-90.
   PubMed     Text format     Related articles    Abstract available
   
   
   

   
   Cancer Chemother Pharmacol

8. KITAGAWA C , Saka H, Kajikawa S, Mori K, et al
   Phase I and pharmacologic study of weekly amrubicin in patients with refractory or relapsed lung cancer: Central Japan Lung Study Group (CJLSG) 0601 trial.
   Cancer Chemother Pharmacol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. KOLINSKY K , Tovar C, Zhang YE, Railkar A, et al
   Preclinical evaluation of the novel multi-targeted agent R1530.
   Cancer Chemother Pharmacol. 2011;68:1585-94.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. SOTO E , Staab A, Doege C, Freiwald M, et al
    Comparison of different semi-mechanistic models for chemotherapy-related neutropenia: application to BI 2536 a Plk-1 inhibitor.
    Cancer Chemother Pharmacol. 2011;68:1517-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Cancer Lett

11. QIN S , Yang C, Li S, Xu C, et al
    Smac: its role in apoptosis induction and use in lung cancer diagnosis and treatment.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Cancer Res

12. ZIGLER M , Kamiya T, Brantley EC, Villares GJ, et al
    PAR-1 and Thrombin: The Ties That Bind the Microenvironment to Melanoma Metastasis.
    Cancer Res. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. XIN H , Herrmann A, Reckamp K, Zhang W, et al
    Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.
    Cancer Res. 2011;71:6601-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. YI H , Guo C, Yu X, Gao P, et al
    Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.
    Cancer Res. 2011;71:6611-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Cancer Res

15. DOEBELE RC , Pilling AB, Aisner D, Kutateladze TG, et al
    Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non-Small Cell Lung Cancer.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. PIETANZA MC , Kadota K, Huberman K, Sima CS, et al
    Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methyl-Guanine-DNA Methyltransferase as a Potential Biomarker.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. VALENCIA K , Ormazabal C, Zandueta C, Luis-Ravelo D, et al
    Inhibition of collagen receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing and Colonization in Lung Cancer Bone Metastasis.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. GILLIES SD , Lan Y, Hettmann T, Brunkhorst B, et al
    A low-toxicity IL-2-based immunocytokine retains antitumor activity despite its high degree of IL-2 receptor selectivity.
    Clin Cancer Res. 2011;17:3673-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. BROET P , Dalmasso C, Tan EH, Alifano M, et al
    Genomic profiles specific to patient ethnicity in lung adenocarcinoma.
    Clin Cancer Res. 2011;17:3542-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Exp Metastasis

20. QIAN Y , Hua E, Bisht K, Woditschka S, et al
    Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain.
    Clin Exp Metastasis. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. KUSUMA N , Anderson RL, Pouliot N
    Laminin alpha5-derived peptides modulate the properties of metastatic breast tumour cells.
    Clin Exp Metastasis. 2011;28:909-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. IBRAHIM HASHIM A , Cornnell HH, Coelho Ribeiro Mde L, Abrahams D, et al
    Reduction of metastasis using a non-volatile buffer.
    Clin Exp Metastasis. 2011;28:841-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. NAKAMURA T , Matsumine A, Matsubara T, Asanuma K, et al
    Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases.
    Clin Exp Metastasis. 2011;28:819-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SHIN JW , Son JY, Raghavendran HR, Chung WK, et al
    High-dose ionizing radiation-induced hematotoxicity and metastasis in mice model.
    Clin Exp Metastasis. 2011;28:803-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Lung Cancer

25. ZHAO Y , Li Y, Lu H, Chen J, et al
    Association of copy number loss of CDKN2B and PTCH1 with poor overall survival in patients with pulmonary squamous cell carcinoma.
    Clin Lung Cancer. 2011;12:328-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. LI Y , Chen KZ, Wang J
    Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people.
    Clin Lung Cancer. 2011;12:313-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Clin Nucl Med

27. TOMITA H , Kita T, Hayashi K, Kosuda S, et al
    Radiation-Induced Myositis Mimicking Chest Wall Tumor Invasion in Two Patients With Lung Cancer: A PET/CT Study.
    Clin Nucl Med. 2012;37:168-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Eur J Cardiothorac Surg

28. STEGER V , Spengler W, Hetzel J, Veit S, et al
    Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
    Eur J Cardiothorac Surg. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. RAMOS R , Girard P, Masuet C, Validire P, et al
    Mediastinal lymph node dissection in early-stage non-small cell lung cancer: totally thoracoscopic vs thoracotomy.
    Eur J Cardiothorac Surg. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. YAMASHITA SI , Tokuishi K, Anami K, Moroga T, et al
    Thoracoscopic segmentectomy for T1 classification of non-small cell lung cancer: a single center experience.
    Eur J Cardiothorac Surg. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. MORDANT P , Arame A, De Dominicis F, Pricopi C, et al
    Which metastasis management allows long-term survival of synchronous solitary M1b non-small cell lung cancer?
    Eur J Cardiothorac Surg. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. KANEDA M , Yokoi K, Ito S, Niwa H, et al
    The value of pleural lavage cytology examined during surgery for primary lung cancer.
    Eur J Cardiothorac Surg. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. CAGINI L , Capozzi R, Tassi V, Savignani C, et al
    Fluid and electrolyte balance after major thoracic surgery by bioimpedance and endocrine evaluation.
    Eur J Cardiothorac Surg. 2011;40:e71-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Int J Oncol

34. LIU W , Xu J, Wang M, Wang Q, et al
    Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway.
    Int J Oncol. 2011;39:1213-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Cancer Res Clin Oncol

35. HAHN N , Heiden M, Seitz R, Salge-Bartels U, et al
    Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
    J Cancer Res Clin Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Immunol

36. GARRIDO G , Rabasa A, Sanchez B, Lopez MV, et al
    Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.
    J Immunol. 2011;187:4954-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Natl Cancer Inst

37. SPHYRIS N , Mani SA
    pIgR: frenemy of inflammation, EMT, and HCC progression.
    J Natl Cancer Inst. 2011;103:1644-5.
    PubMed     Text format     Related articles   
    
    
    
38. AI J , Tang Q, Wu Y, Xu Y, et al
    The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.
    J Natl Cancer Inst. 2011;103:1696-712.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Nucl Med

39. DOLESCHEL D , Mundigl O, Wessner A, Gremse F, et al
    Targeted Near-Infrared Imaging of the Erythropoietin Receptor in Human Lung Cancer Xenografts.
    J Nucl Med. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    J Thorac Cardiovasc Surg

40. RUSCH VW
    Mediastinoscopy: an obsolete procedure?
    J Thorac Cardiovasc Surg. 2011;142:1400-2.
    PubMed     Text format     Related articles   
    
    
    

    
    J Thorac Oncol

41. MACHTAY M , Paulus R, Moughan J, Komaki R, et al
    Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma: A Radiation Therapy Oncology Group Analysis.
    J Thorac Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. FENG Y , Thiagarajan PS, Ma PC
    MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer.
    J Thorac Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. DZIADZIUSZKO R , Wynes MW, Singh S, Bernadette Reyna A, et al
    Correlation between MET Gene Copy Number by Silver In Situ Hybridization and Protein Expression by Immunohistochemistry in Non-small Cell Lung Cancer.
    J Thorac Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. WEICKHARDT A , Doebele R, Oton A, Lettieri J, et al
    A Phase I/II Study of Erlotinib in Combination with the Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody IMC-A12 (Cixutumumab) in Patients with Advanced Non-small Cell Lung Cancer.
    J Thorac Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. LIU G , Cheng D, Ding K, Le Maitre A, et al
    Pharmacogenetic Analysis of BR.21, a Placebo-Controlled Randomized Phase III Clinical Trial of Erlotinib in Advanced Non-small Cell Lung Cancer.
    J Thorac Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Lung Cancer

46. ISHIKAWA M , Miyahara R, Sonobe M, Horiuchi M, et al
    Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. YIRMIBESOGLU E , Higginson DS, Fayda M, Rivera MP, et al
    Challenges scoring radiation pneumonitis in patients irradiated for lung cancer.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. HEUVERS ME , Aerts JG, Hegmans JP, Veltman JD, et al
    History of tuberculosis as an independent prognostic factor for lung cancer survival.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. CROMWELL I , van der Hoek K, Malfair Taylor SC, Melosky B, et al
    Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. GAO G , Chu H, Zhao L, Gui T, et al
    A meta-analysis of paclitaxel-based chemotherapies administered once every week compared with once every 3 weeks first-line treatment of advanced non-small-cell lung cancer.
    Lung Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. PIACENTINI F , Rossi G, Casali C, Cadioli A, et al
    Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications.
    Lung Cancer. 2011;74:145-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. YATABE Y , Borczuk AC, Powell CA
    Do all lung adenocarcinomas follow a stepwise progression?
    Lung Cancer. 2011;74:7-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Mol Carcinog

53. ZHANG X , Li X, Wu Z, Lin F, et al
    The p73 G4C14-to-A4T14 polymorphism is associated with risk of lung cancer in the Han nationality of North China.
    Mol Carcinog. 2012 Jan 6. doi: 10.1002/mc.21869.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    N Engl J Med

54. HEUVERS ME , Stricker BH, Aerts JG
    Generalizing lung-cancer screening results.
    N Engl J Med. 2012;366:192-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. GAVIN MC , Morse D, Partridge AH, Levy BD, et al
    Clinical problem-solving. Breathless.
    N Engl J Med. 2012;366:75-81.
    PubMed     Text format     Related articles   
    
    
    

    
    Oncogene

56. HOLLEMAN A , Chung I, Olsen RR, Kwak B, et al
    miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.
    Oncogene. 2011;30:4386-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Oncol Rep

57. JI BC , Yu CC, Yang ST, Hsia TC, et al
    Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells.
    Oncol Rep. 2012 Jan 4. doi: 10.3892/or.2012.1622.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Proc Natl Acad Sci U S A

58. GAO Q , Steine EJ, Barrasa MI, Hockemeyer D, et al
    Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression.
    Proc Natl Acad Sci U S A. 2011;108:18061-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    

    
    Thorax

59. MASTRANGELO G , Rylander R, Cegolon L, Lange J, et al
    Lung cancer risk in subjects exposed to organic dust: an unexpected and surprising story.
    Thorax. 2012.
    PubMed     Text format     Related articles   
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: